Targets of perturbagens

Perturbagen ID Perturbagen Reference Target Number Response ID
CID54631 Isis 113715 DrugBank 1  NA
CID54632 Vx-765 CLUE; DrugBank 2  RID31466 RID31467 RID31468 RID31469 RID31470 RID31471 RID31712 RID31713 RID31714 RID31715 RID31716 RID31717 RID31959 RID31960 RID31961 RID31962 RID31963 RID31964
CID54633 Li-301 DrugBank 2  NA
CID54634 Huperzine-a CLUE; STITCH; DrugBank 1  RID53544 RID53789 RID54032 RID54121 RID54358 RID56362 RID56601 RID56807 RID56831 RID56855 RID56878 RID56924 RID56949 RID56977 RID57000 RID57023 RID57046 RID57068 RID57091 RID57112 RID57159 RID57179 RID57203 RID57228 RID57253
CID54635 Piclidenoson DrugBank 1  NA
CID54636 (1s,3ar,6as)-(2s)-2-cyclohexyl-n-(pyrazinylcarbonyl)glycyl-3-methyl-l-valyl-n-((1s)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide; Incivek; Telaprevir DrugBank; CLUE; STITCH 9  NA
CID54637 Brivaracetam; Briviact; Brivlera DrugBank; STITCH 2  NA
CID54638 Cyramza; Ramucirumab DrugBank 1  NA
CID54639 Fareletuzumab; Farletuzumab DrugBank 1  NA
CID54640 Antimony (v) derivative of sodium gluconate; Antimony sodium gluconate; Estibogluconato sodico; Myostibin; Natrii stibogluconas; Sodium stibogluconate; Stibanate; Stibanose; Stibatin; Stibinol; Stibogluconate de sodium; Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate DrugBank; STITCH 2  NA